Prompt initiation of anti-TB drugs, including isoniazid, rifampicin, pyrazinamide, and ethambutol, targets the underlying infection and subsequently reduces systemic inflammation by decreasing the release of pro-inflammatory cytokines such as IL-6. This evidence concerns the gene IL6 and infection.